Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates
- PMID: 35882487
- PMCID: PMC9345222
- DOI: 10.7861/clinmed.2022-0112
Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates
Abstract
Introduction: Hyperglycaemia is related to poorer outcomes among hospital inpatients. We investigated the impact of hyperglycaemia at admission on length of hospital stay, readmission rate and mortality rate.
Method: We retrospectively analysed the records of 1,132 patients admitted to hospital in January 2019, April 2019, August 2019 and April 2020.
Results: Hyperglycaemia was present in 14.1% of patients. New-onset hyperglycaemia on admission (in 3.9% of patients) was related to a higher mortality rate than in patients known to have diabetes admitted with hyperglycaemia (43.3% vs 17.9%; p=0.006). Mortality at 90 days and 1 year increased with higher admission glucose levels (p=0.03 and p=0.005, respectively), severe hyperglycaemia (>20 mmol/L) having a 1-year mortality of 34.3%. After accounting for confounding variables, admission glucose and length of stay remained significant predictors of 1-year mortality (p=0.034 and p=0.003, respectively).
Conclusion: Hyperglycaemia is an important prognostic marker and may indicate a more severe illness. These patients should be highlighted for a greater level of care.
Keywords: diabetes mellitus; hyperglycaemia; morbidity; mortality.
© Royal College of Physicians 2022. All rights reserved.
Figures
References
-
- Government of Malta . Diabetes: A national public health priority. Government of Malta, 2016. https://deputyprimeminister.gov.mt/en/Documents/National-Health-Strategi... [Accessed 03 March 2022].
-
- Campbell RK. Etiology and effect on outcomes of hyperglycemia in hospitalized patients. Am J Health Syst Pharm 2007;64 (10 Suppl 6):S4–8. - PubMed
-
- Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978–82. - PubMed
-
- Norhammar AM, Rydén L, Malmberg K. Admission plasma glucose. Independent Risk Factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999;22:1827–31. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
